Citations

Showing 10 of 108152 citations.

High‐Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change
Pokharel, Yashashwi , Mouhanna, Farah , Nambi, Vijay , Heiss, Gerardo , Selvin, Elizabeth , Ballantyne, Christie M. , Selvin, Elizabeth , Selvin, Elizabeth , Ballantyne, Christie M , Schneider, Andrea L.C. , Rawlings, Andreea M. , Knopman, David S. , Virani, Salim S. , Hoogeveen, Ron Cornelis , Alonso, Álvaro , Coresh, Josef , Mosley, Thomas H. , Gottesman, Rebecca F. , Power, Melinda C.

Mayo Clinic

Journal of the American Geriatrics Society | July 30, 2019 | Volume: 67 | Issue: 11 | Pages: 2353-2361

10.1111/jgs.16092 | PMID 31359423 Get It

OBJECTIVES Cardiac troponin T, measured using a high‐sensitive assay (hs‐cTnT), and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) are associated with increased stroke risk and perhaps with cognitive decline. However, few well‐designed prospective studies with extended follow‐up have been conducted. We aimed to estimate the association of hs‐cTnT and NT‐proBNP with 15‐year cognitive change in the Atherosclerosis Risk in Communities (ARIC) study. DESIGN Prospective cohort study. SETTING Four US communities. PARTICIPANTS A total of 9114 and 9108 participants from the Atherosclerosis Risk in Communities study for analyses of hs‐cTnT and NT‐proBNP, respectively. MEASUREMENTS We examined association of hs‐cTnT and NT‐proBNP with 15‐year change (1996‐1998 to 2011‐2013) in three cognitive tests of executive function (Digit Symbol Substitution Test), verbal learning memory (Delayed Word Recall Test), and semantic fluency (Word Fluency Test), and an overall score combining the three tests using multivariable linear mixed effect models. We conducted several sensitivity analyses including multiple imputations to address bias due to missing data and attrition, and we compared associations within groups combining hs‐cTnT and NT‐proBNP into a three‐level categorical variable. RESULTS At baseline (1996‐1998), mean age was 63.4 (standard deviation [SD] = 5.7) years; 56.4% were women, and 17.5% were black. The hs‐cTnT at baseline was not associated with cognitive change in any measure. Some evidence indicated accelerated decline in verbal learning and memory when comparing those in the highest with the lowest NT‐proBNP quintiles; however, this association was not replicated when considering clinically relevant cutoffs or deciles of exposure in survivors. Sensitivity analyses were consistent with our primary analyses. There was little evidence to support effect modification by any considered factors. People with highest levels of both biomarkers had excessive decline in global z scores vs people with lowest levels (−.34; 95% confidence interval = −.63 to −.04). CONCLUSION Markers of myocardial injury and stretch were not associated with cognitive decline following 15 years among survivors, but when combined together they were suggestive in post hoc analysis. Whether this represents targets of intervention should be examined in the future. J Am Geriatr Soc 67:2353–2361, 2019
Tools of the Trade: How Do You Perform and Interpret an Exercise Test?
Rischard, Franz , Borlaug, Barry A.

Mayo Clinic

Advances in Pulmonary Hypertension | July 29, 2019 | Volume: 18 | Issue: 2 | Pages: 47-55

10.21693/1933-088x-18.2.47 Get It

Background: Most pulmonary vascular disease (PVD) is poorly modifiable and incurable even with effective therapy. Therefore, adaptation to stress, the reserve of the cardiopulmonary system, is important for assessment of patient function and prognosis. Methods that assess the adaptation to stress, especially exercise, provide valuable insight into diagnosis, prognosis, and response to therapy.Implications for Clinicians: We provide a comprehensive review of the indications, methodology, and interpretation, as well as practical information of the forms of provocative testing in PVD. We include 6-minute walk testing, noninvasive cardiopulmonary exercise testing (CPET), invasive CPET, and additional forms, including volume loading.Conclusions: Through a clear understanding of the methodology in the assessment of PVD, the clinician can determine which of these “tools of the trade” are best suited to the individual patient and situation.
Clinician‐patient communication during the diagnostic workup: The ABIDE project
Visser, Leonie N.C. , Kunneman, Marleen , Murugesu, Laxsini , Maurik, Ingrid S. van , Zwan, Marissa D. , Schuur, Jacqueline, Wind, Hilje A., Blaauw, M., Kragt, Jolijn J, Roks, Gerwin , Boelaarts, Leo, Schipper, Annemieke C, Schooneboom, Niki, Scheltens, Philip , Smets, Ellen M.A. , Scheltens, Philip , Bouwman, Femke H. , Flier, Wiesje M. van der

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | July 29, 2019 | Volume: 11 | Issue: 1 | Pages: 520-528

10.1016/j.dadm.2019.06.001 | PMID 31388556 Get It

AbstractIntroductionWe aimed to describe clinician‐patient communication in the diagnostic process of memory clinics, specifically clinician behavior known to facilitate knowledgeable participation of patients during consultations.MethodsIn this multicenter, observational study, we audio‐recorded routine diagnostic consultations of 41 clinicians and 136 patients/caregivers at eight memory clinics. Patients/caregivers completed surveys after each audiotaped consultation. We used a study‐specific coding scheme to categorize communication behavior.ResultsClinicians often provided information on (results of) diagnostic testing. They infrequently invited questions and/or checked understanding. Clinician behavior to involve patients in decision‐making about diagnostic testing was limited. Of note, patients/caregivers rarely expressed their information or involvement preferences. Yet, approximately, one quarter of them would have liked to receive more information.DiscussionInvolving patients more explicitly by means of shared decision‐making could benefit the quality of care provided in memory clinics because it enables clinicians to attune the diagnostic workup to the individual patient's needs.
Ethicists’ Opinions Regarding the Permissibility of Face Transplant
Suchyta, Marissa , Amer, Hatem , Mardini, Samir , Suchyta, Marissa A, Sharp, Richard, Amer, Hatem , Sharp, Richard R. , Bradley, Elizabeth A.

Mayo Clinic

Plastic & Reconstructive Surgery | July 29, 2019 | Volume: 144 | Issue: 1 | Pages: 212-224

10.1097/prs.0000000000005748 | PMID 31246832 Get It

Background: Face transplantation can offer functional and aesthetic restoration to patients who have exhausted their reconstructive options, improving quality of life and psychosocial integration. Ethical issues in face transplantation abound, including questions of patient selection and evaluation before transplantation. To date, there has been no study of ethicists’ opinions regarding face transplantation. Methods: An online survey of attendees of the 2015 International Conference on Clinical Ethics Consultation (n = 401) assessed ethicists’ opinions about face transplantation. Questions examined the risk-to-benefit ratio of immunosuppression; permissibility of face transplantation in subpopulations (including children and blind patients); donor-recipient age, sex, and ethnicity mismatches; and ethical oversight. Results: Most ethicists (84 percent) agreed that it is permissible to perform a face transplantation on an adult in the absence of clear medical contraindications. Most respondents also agreed that it is permissible to perform a face transplantation on a child (62 percent) or a blind patient (61 percent), yet demonstrated less consensus regarding the permissibility of performing a face transplantation on patients with an increased risk of immune rejection. Respondents were generally supportive of age, sex, and ethnicity mismatches, with 43 percent indicating that it is permissible to have a sex mismatch. The majority answered that face transplantation should be covered by federal insurance (74 percent). Conclusions: This study provides insight into clinical ethicists’ views regarding face transplantation. Most ethicists support the ethical permissibility of face transplantation, and did not have concerns about age, sex, and ethnicity mismatches. These findings highlight emerging areas of consensus regarding the ethical permissibility of face transplantation.
Association between the Charlson comorbidity index and outcomes after implantable cardioverter defibrillator generator replacement
Amin, Mustapha M., Witt, Chance M. , Waks, Jonathan W. , Mehta, Ramila A. , Friedman, Paul A. , Kramer, Daniel B. , Buxton, Alfred E. , Mulpuru, Siva K. , Hodge, David O. , Frey, Rebecca J., Frederick, Nicolette K., Cha, Yong‐Mei , Brenes-Salazar, Jorge A., Madhavan, Malini , Brenes-Salazar, Jorge

Mayo Clinic

Pacing and Clinical Electrophysiology | July 29, 2019 | Volume: 42 | Issue: 9 | Pages: 1236-1242

10.1111/pace.13762 | PMID 31355952 Get It

AbstractBackgroundRecipients of implantable cardioverter defibrillator (ICD) generator replacement with multiple medical comorbidities may be at higher risk of adverse outcomes that attenuate the benefit of ICD replacement. The aim of this investigation was to study the association between the Charlson comorbidity index (CCI) and outcomes after ICD generator replacement.MethodsAll patients undergoing first ICD generator replacement at Mayo Clinic, Rochester and Beth Israel Deaconess Medical Center, Boston between 2001 and 2011 were identified. Outcomes included: (a) all‐cause mortality, (b) appropriate ICD therapy, and (c) death prior to appropriate therapy. Multivariable Cox regression analysis was performed to assess association between CCI and outcomes.ResultsWe identified 1421 patients with mean age of 69.6 ± 12.1 years, 81% male and median (range) CCI of 3 (0‐18). During a mean follow‐up of 3.9 ± 3 years, 52% of patients died, 30.6% experienced an appropriate therapy, and 23.6% died without experiencing an appropriate therapy. In multivariable analysis, higher CCI score was associated with increased all‐cause mortality (Hazard ratio, HR 1.10 [1.06‐1.13] per 1 point increase in CCI, P < .001), death without prior appropriate therapy (HR 1.11 [1.07‐1.15], P < .0001), but not associated with appropriate therapy (HR 1.01 [0.97‐1.05], P = .53). Patients with CCI ≥5 had an annual risk of death of 12.2% compared to 8.7% annual rate of appropriate therapy.ConclusionsCCI is predictive of mortality following ICD generator replacement. The benefit of ICD replacement in patients with CCI score ≥5 should be investigated in prospective studies.
Peer support: A needs assessment for social support from trained peers in response to stress among medical physicists
Johnson, Jennifer , Ford, Eric , Yu, James B. , Buckey, Courtney, Fogh, Shannon , Evans, Suzanne B. , Evans, Suzanne , Yu, James B

Mayo Clinic

Journal of Applied Clinical Medical Physics | July 29, 2019 | Volume: 20 | Issue: 9 | Pages: 157-162

10.1002/acm2.12675 | PMID 31355990 Get It

AbstractPurposePrevious studies suggest that within radiation oncology, medical physicists (MP) experience high workloads. Little is known about how MPs use social support (SS) in times of stress.MethodsIn collaboration with the Workgroup on Prevention of Medical Error, the American Association of Physicists in Medicine administered this Human Investigation Committee (HIC) approved email survey to 8566 members. Respondents were considered likely to seek SS if they answered (probably/definitely would) and unlikely to seek support if they answered (probably/definitely would not). Logistic regression was applied to determine associations between demographic factors and willingness to seek support as well as perception of barriers.ResultsOne thousand two hundred and ninety‐seven members (15.1%) accessed and gave consent for the survey. One thousand and one (11.7%) respondents answered all relevant questions. Respondents were predominantly male (69.1%), MP in radiation oncology (81.8%), private practice (51.6%), with practice duration> 10 yr (60.2%). MPs were likely to seek SS for personal physical illness (78.63%), involvement in a medical error (73.94%) or adverse patient outcome (75.17%). MPs sought SS in the setting of personal fatigue (33.2%) or burnout (44.3%). Barriers to seeking SS were lack of time (80.3%), and uncertainty about whom to access (70.7%). MPs responded that they would be most likely to seek support from an equally experienced medical physicist colleague (81.0%). Most MPs (67.0%) identified as having experienced stressors, with serious family illness (35.2%), or burnout (32.8%) being most common. Factors associated with MPs unwillingness to seek SS for medical error included> 20 yr in practice (vs still in training — OR 0.30, P = 0.015), and male gender (OR 0.60, P = 0.003). Male gender was associated with the lowest willingness to seek support (OR 2.10, P = 0.0001), but also with fewer perceived barriers (OR 1.60, P = 0.0075).ConclusionWillingness to seek SS is demonstrated, and MPs want colleagues to provide support. Given these results, peer support could be considered among MPs.
Arteries of the Face and Their Relevance for Minimally Invasive Facial Procedures: An Anatomical Review
Lachman, Nirusha , Cotofana, Sebastian

Mayo Clinic

Plastic & Reconstructive Surgery | July 29, 2019 | Volume: 143 | Issue: 2 | Pages: 416-426

10.1097/prs.0000000000005201 | PMID 30688884 Get It

Background: The purpose of this article is to provide a comprehensive review based on images and discussion of the current understanding of the arterial supply of the face to facilitate safe minimally invasive antiaging procedures. Methods: Contrast-enhanced computed tomographic scans of 40 fresh frozen heads from 17 male and 23 female Caucasian body donors with a mean age of 76.9 ± 13.1 years and a mean body mass index of 23.6 ± 5.3 kg/m2 were retrospectively analyzed and compared to cadaveric dissections performed in more than 400 fresh cephalic specimens. Results: This review presents the current understanding of the facial arteries based on existing literature, direct observation from cadaveric dissection, and the dissection experience of the two authors of the study. It reveals the constant three-dimensional locations of the facial and angular arteries: mandible, modiolus, and medial canthus as compared to their unpredictable course in other facial regions. In addition, the anatomy of the ophthalmic and central retinal arteries is discussed in the context of current treatment strategies in cases of blindness following facial soft-tissue filler injections. Conclusions: The arterial supply of the face exhibits high variability in branching patterns, course (two-dimensional), and depth (three-dimensional). Because of the lack of predictability of the vascular anatomy, it is impossible to absolutely guarantee safety when performing minimally invasive injectable procedures. Injectors should understand the potential for adverse vascular events, communicate this risk appropriately to patients, and be properly trained and equipped to treat any such complication.
Reconstruction of Oncologic Sternectomy Defects: Lessons Learned from 60 Cases at a Single Institution
Banuelos, Joseph, Bite, Uldis, Moran, Steven L. , Bakri, Karim , Pairolero, Peter C., Arnold, Philip G., Sharaf, Basel , Abu-Ghname, Amjed, Blackmon, Shanda H, Shen, Robert, Allen, Mark S. , Abu‐Ghname, Amjed , Blackmon, Shanda , Shen, Robert K. , Sharaf, Basel A

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | July 29, 2019 | Volume: 7 | Issue: 7 | Pages: e2351

10.1097/gox.0000000000002351 | PMID 31942367 Get It

Background: Oncologic sternectomy results in complex defects where preoperative planning is paramount to achieve best reconstructive outcomes. Although pectoralis major muscle flap (PMF) is the workhorse for sternal soft tissue coverage, additional flaps can be required. Our purpose is to evaluate defects in which other flaps beside PMF were required to achieve optimal reconstruction. Methods: A retrospective review of consecutive patients at our institution who underwent reconstruction after sternal tumor resection was performed. Demographics, surgical characteristics, and outcomes were evaluated. Further analysis was performed to identify defect characteristics where additional flaps to PMF were needed to complete reconstruction. Results: In 11 years, 60 consecutive patients were identified. Mean age was 58 (28–81) years old, with a mean follow-up of 40.6 (12–64) months. The majority were primary sternal tumors (67%) and the mean defect size was 148 cm2 (±81). Fourteen (23%) patients presented with postoperative complications, and the 30-day mortality rate was 1.6%. In 19 (32%) cases, additional flaps were required; the most common being the rectus abdominis muscle flaps. Larger thoracic defects (P = 0.011) and resections involving the inferior sternum (P = 0.021) or the skin (P = 0.011) were more likely to require additional flaps. Conclusions: Reconstruction of oncologic sternal defects requires a multidisciplinary team approach. Larger thoracic defects, particularly those that involve the skin and the inferior sternum, are more likely to require additional flaps for optimal reconstruction.
Subclinical hypothyroidism in pregnancy
Toloza, Freddy J.K. , Abedzadeh-Anaraki, Sanaz, Maraka, Spyridoula , Maraka, Spyridoula

Mayo Clinic

Current Opinion in Endocrinology, Diabetes & Obesity | July 29, 2019 | Volume: 26 | Issue: 5 | Pages: 225-231

10.1097/med.0000000000000491 | PMID 31356254 Get It

Purpose of review Subclinical hypothyroidism (SCH) is a common diagnosis among women of reproductive age. The importance of sufficient maternal thyroid supply during pregnancy is well known. Nevertheless, the effects of SCH during pregnancy and the efficacy of its treatment on maternofetal outcomes are not well established. This review discusses the recent evidence on SCH in pregnancy and how this evidence is reflected in current clinical care. Recent findings Recent observational studies have found a positive association between SCH during pregnancy and adverse maternal, neonatal and offspring outcomes, mainly in thyroid peroxidase autoantibody positive women. Although interventional studies have shown a benefit of levothyroxine (LT4) treatment on selected pregnancy outcomes, there was no effect on offspring neurodevelopment. Summary Current evidence strengthens the association between SCH with both maternofetal and offspring adverse outcomes. An earlier and more individualized diagnostic assessment taking into consideration predictors of thyroid dysfunction and major risk factors for complications could result in better management of SCH during pregnancy. The effectiveness of LT4 on improving maternofetal and long-term offspring outcomes is still not fully elucidated.
Faculty Opinions recommendation of Recapitulating bone development through engineered mesenchymal condensations and mechanical cues for tissue regeneration.
Evans, Christopher H.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 29, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.735919013.793563035 Get It